ZSANQ Projected Dividend Yield
Com Par $0.001/Zosano Pharma Corp ( OTCBB : ZSANQ )Zosano Pharma is a clinical stage biopharmaceutical company focused on providing systemic administration of therapeutics to patients using its proprietary intracutaneous microneedle system (the System). Co.'s development activities are focused on its product candidate, Qtrypta™ (M207). Qtrypta™ (M207) is Co.'s proprietary formulation of zolmitriptan delivered utilizing its System. Zolmitriptan is one of a class of serotonin receptor agonists known as triptans and is used as an acute treatment for migraine. Qtrypta™ (M207) is designed for absorption of zolmitriptan into the bloodstream without dependence on the gastrointestinal tract. 20 YEAR PERFORMANCE RESULTS |
ZSANQ Dividend History Detail ZSANQ Dividend News ZSANQ Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |